In a significant step forward, researchers are initiating targeted experimental studies to decode the epigenetic mechanisms contributing to long-term immune suppression in sepsis survivors. Leveraging advanced MAPit-FENGC protocols and validating candidate biomarkers in relevant tissue models, there is cautious optimism that these epigenetic signatures will offer actionable insights. The consistent support across analytical pillars underscores a shared commitment to exploring these promising biomarkers and intervention targets, even as questions remain regarding the precise drivers of post-sepsis immunosuppression.
“we present a systems-level framework that demonstrates how epigenetic regulation controls ageing.”
“This framework reveals why therapeutics targeting epigenetic systems have consistent effects across multiple model systems and ageing phenotypes.”
“The interconnected organization of chromatin regulation mechanisms creates concrete therapeutic targets to restore regulatory coherence.”
“Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets.”
“Fast-evolving human-specific neural enhancers are associated with aging-related diseases. Cell Syst. 6, 604–611 (2018).”
“Nuclear lamina defects cause ATM-dependent NF-κB activation and link accelerated aging to a systemic inflammatory response.”
“Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion.”
“Aging is associated with increased chromatin accessibility and reduced polymerase pausing in liver.”
“Aging activates escape of the silent X chromosome in the female mouse hippocampus.”
“PRC2-AgeIndex as a universal biomarker of aging and rejuvenation.”
“Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation.”
“Systemic epigenetic dysregulation as a driver of ageing and a therapeutic target.”
